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Gene 33/Mig6 Regulates Apoptosis and the DNA Damage Response
through Independent Mechanisms

Abstract
#5524

Cen Li, Soyoung Park, Xiaowen Zhang, Leonard M. Eisenberg, Hong Zhao, Zbigniew Darzynkiewicz, and Dazhong Xu
Department of Pathology, Department of Physiology, New York Medical College, Valhalla, New York
ABSTRACT
Gene 33 (Mig6, ERRFI1) is an inducible adaptor/scaffold
protein whose expression can be induced by both stress
and mitogenic signals. It contains multiple domains for
protein-protein interaction and is involved in a broad
spectrum of cellular functions. Gene 33 promotes
apoptosis in a cell type-dependent manner. A recent study
has linked Gene 33 to the DNA damage response (DDR)
induced by hexavalent chromium [Cr(VI)]. Here we show
that Gene 33 induces apoptosis via both c-Abl/p73 and
EGFR/AKT-dependent pathways in lung epithelial and lung
carcinoma cells. Ectopic expression of Gene 33 also
triggers DDR in an ATM-dependent fashion and through
pathways with or without association with apoptosis. We
observed significant presence of Gene 33 in the nucleus
and chromatin. We show that the nuclear localization of
Gene 33 is dependent on its 14-3-3 binding domain. We
find that the chromatin localization of Gene 33 is, at least in
part, dependent on its EBD motif. Our data also show that
Gene 33 may regulate chromatin targeting of c-Abl and
EGFR. Moreover, we observed strong association of Gene
33 with histone H2AX and that Gene 33 promotes
interaction between ATM and histone H2AX without
triggering DNA damage. Our study reveals novel nuclear
functions of Gene 33, which mediate DDR and apoptosis
through independent mechanisms. Given our previous
finding that Gene 33 depletion promotes Cr(VI)-induced
DNA damage, our data suggest that Gene 33 may foster
DNA repair by activating DDR.

RESULTS
Confocal images of BEAS-2B
cells ectopically expressing
FLAG-tagged wild type or 1308AA of Gene33. green:
FLAG, blue: DAPI.
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Figure 3. Wild type but not Gene 33Y356A modestly inhibits cell proliferation and triggers
apoptosis. Cell counting and IB detecting the indicated proteins in A549 cells after infected with
adenoviral vectors encoding β-Gal, wild type Gene 33, or EBD mutant (YA) Gene 33. Laser scanning
cytometry measuring cell cycle distributions of A549 and BEAS-2B cells after infected with the adenoviral
vectors.

BACKGROUND

Figure 1. Linear structure of Gene 33.
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Figure 4. Ectopic expression of Gene 33 induces apoptosis in
an EBD-dependent but p53-independent manner and provokes
DDR in an EBD-independent fashion. IB detecting the indicated
proteins in A549 and BEAS-2B cells infected with the indicated
adenoviral vectors, and in 293T cells transfected with the indicated
expression plasmids.

Figure 7. Ectopic expression
of Gene 33 does not trigger
DNA damage. A549 cells were
either untreated (Control), or
treated with UV for 30s and
then recovered for 2h (UV), or
infected with the indicated
adenoviral vectors for 24h.
Cells were then used to detect
DNA damage by the comet
assay. Representative images
of the comet assay were
shown and the DNA damage
index (percentage of DNA in
tail) was determined using the
the OpenComet comet assay
software (*P < 0.05).

Figure 6. Nuclear localization of Gene 33. Cell fractionation assay on A549 (left)
BEAS-2B (middle) cells with or without infected with the indicated adenoviral vectors.
T: total, C: cytoplasm, N: nucleus, Ch: chromatin, Gene 33YA: Gene 33 EBD mutant,
S: short exposure, L: long exposure, Mig6: Mig6 antibody. Right: confocal imaging
showing nuclear signals of Gene 33.
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Figure 2. A potential role of Gene 33 in Cr(VI)-induced lung
carcinogenesis. Cr(VI) reduces the levels of Gene 33 mRNA and
Protein, which inhibits Cr(VI)-induced DNA damage that lead to
genomic instability, cell transformation and carcinogenesis.
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Figure 5. Gene 33 induces apoptosis in a c-Abl/p73-dependent and DDR in an ATM-dependent
fashion. A549 or BEAS-2B cells were infected with the indicated adenoviral vectors and treated with the
c-Abl inhibitor Nilotinib (Nilo), the EGFR kinase inhibitor AG1478 (AG), the ATM/ATR inhibitor caffeine
(Caf), or the ATM kinase inhibitor KU55933 (KU). The indicated proteins were detected by IB.

Figure 8. Gene 33 binds to histone H2AX and promotes interaction between ATM and histone
H2AX. BEAS-2B cells were infected with the indicated adenoviral vectors followed by IP and IB as
indicated. Far right: 293T cells were transfected with expression plasmids encoding FLAG-tagged
wild type Gene 33 or Gene 33 with EBD mutation (Gene 33YA) with or without co-transfection of
His-tagged ATM followed by HIS pulldown and IB as indicated.

Figure 9. A proposed model on the
regulation of apoptosis and DDR by Gene
33. Gene 33 binds and activates c-Abl
thereby triggering the p73-dependent proapoptotic pathway. Gene 33 may also
promote apoptosis by inhibiting EGFR and
AKT-mediated pro-survival pathway. Both of
these pathways are dependent the EBD motif
of Gene 33. Gene 33 activates DDR
(manifested as γH2AX) via both a c-Abl/EBDdependent pathway and a c-Abl/EBDindependent
pathway
through
direct
activation of c-Abl and promoting ATMhistone H2AX interaction, respectively. Both
pathways are dependent on ATM to activate
DDR. Apoptosis- and DDR-associated
activities of Gene 33 occur, at least in part, in
the nucleus and/or chromatin.
C: cytoplasm, N: nucleus.

